GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Price-to-Funds-From-Operations

Arctic Bioscience AS (OSL:ABS) Price-to-Funds-From-Operations : (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Arctic Bioscience AS (OSL:ABS) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand.